185 related articles for article (PubMed ID: 7209398)
1. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density.
Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B
Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398
[TBL] [Abstract][Full Text] [Related]
2. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
3. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
4. Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders.
Caranobe C; Sié P; Fernandez F; Pris J; Moatti S; Boneu B
Thromb Haemost; 1984 Jul; 51(3):349-53. PubMed ID: 6593892
[TBL] [Abstract][Full Text] [Related]
5. Relationship between mepacrine-labelled dense body number, platelet capacity to accumulate 14C-5-HT and platelet density in the Bernard-Soulier and Hermansky-Pudlak syndromes.
Rendu F; Nurden AT; Lebret M; Caen JP
Thromb Haemost; 1979 Aug; 42(2):694-704. PubMed ID: 505374
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
Pareti FI; Gugliotta L; Mannucci L; Guarini A; Mannucci PM
Thromb Haemost; 1982 Apr; 47(2):84-9. PubMed ID: 7101243
[TBL] [Abstract][Full Text] [Related]
7. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
Viero P; Cortelazzo S; Bassan R; Barbui T
Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
[TBL] [Abstract][Full Text] [Related]
8. Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay.
Koch CA; Lasho TL; Tefferi A
Br J Haematol; 2004 Oct; 127(1):34-9. PubMed ID: 15384975
[TBL] [Abstract][Full Text] [Related]
9. Serotonin uptake and storage in human platelet density subpopulations.
Caranobe C; Sie P; Boneu B
Br J Haematol; 1982 Oct; 52(2):253-8. PubMed ID: 7126468
[TBL] [Abstract][Full Text] [Related]
10. Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodies.
Rendu F; Breton-Gorius J; Lebret M; Klebanoff C; Buriot D; Griscelli C; Levy-Toledano S; Caen JP
Am J Pathol; 1983 Jun; 111(3):307-14. PubMed ID: 6222656
[TBL] [Abstract][Full Text] [Related]
11. The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets.
Gerrard JM; Rao GH; White JG
Am J Pathol; 1977 Jun; 87(3):633-46. PubMed ID: 405872
[TBL] [Abstract][Full Text] [Related]
12. Exploration of mechanisms of amine storage in the dense bodies of human platelets.
Costa JL; Eanes ED
Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):347-66. PubMed ID: 6095385
[TBL] [Abstract][Full Text] [Related]
13. [ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma].
Terada H; Ohshima M
Rinsho Ketsueki; 1989 Jan; 30(1):22-8. PubMed ID: 2716195
[TBL] [Abstract][Full Text] [Related]
14. Platelet dense bodies loaded with mepacrine. Study in chronic idiopathic thrombocytopenic purpura (ITP).
Hourdille P; Bernard P; Reiffers J; Broustet A; Boisseau MR
Thromb Haemost; 1980 Jul; 43(3):208-10. PubMed ID: 7192892
[TBL] [Abstract][Full Text] [Related]
15. Mepacrine labelling test and uranaffin cytochemical reaction in human megakaryocytes.
Hourdillé P; Fialon P; Belloc F; Boisseau MR; Andrieu JM
Thromb Haemost; 1982 Jun; 47(3):232-5. PubMed ID: 7112496
[TBL] [Abstract][Full Text] [Related]
16. Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
Cortellazzo S; Viero P; Buczko W; Barbui T; de Gaetano G
Scand J Haematol; 1985 Feb; 34(2):146-51. PubMed ID: 3856312
[TBL] [Abstract][Full Text] [Related]
17. Mepacrine, a tool for investigating the 5-hydroxytryptamine organelles of blood platelets by fluorescence microscopy.
Lorez HP; Da Prada M; Rendu F; Pletscher A
J Lab Clin Med; 1977 Jan; 89(1):200-6. PubMed ID: 556622
[TBL] [Abstract][Full Text] [Related]
18. Blood platelet and "extra-platelet" serotonin in some myeloproliferative disorders.
Culebras Poza JM; Launay JM; Briere J; Dreux C
Biomedicine; 1977 Nov; 27(8):300-3. PubMed ID: 597565
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
20. Platelet density analysis: a tool for the detection of acquired storage pool disease in man.
Boneu B; Sié P; Eche N; Caranobe C; Hugo B; Nouvel C
Br J Haematol; 1983 Nov; 55(3):523-32. PubMed ID: 6227333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
